Star Equity Holdings, Inc. (STRR) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $38.6M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerStar Equity Holdings, Inc. (STRR) trades at $10.45 with MoonshotScore 24/100 (Grade F). Market cap: $38.6M, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for STRR: STRR does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates STRR against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
These figures come from statements filed 12 months ago — the most recent this company has published.
STRR: 1/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Strongest side: Growth Durability (7/10, Moderate). Weakest side: Financial Safety (2/10, Negative).
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Why this analysis is different
- A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Star Equity Holdings, Inc. (STRR) Healthcare & Pipeline Overview
Star Equity Holdings, Inc. operates as a diversified holding company, offering healthcare solutions through diagnostic services and imaging systems, alongside a significant presence in the construction sector with modular housing and engineered wood products. This dual-sector approach positions the company across medical diagnostics and building materials markets.
What Is the Investment Thesis for STRR?
Star Equity Holdings, Inc. (STRR) presents a unique investment profile characterized by its diversified operational segments across healthcare and construction, offering potential resilience against sector-specific downturns. The company's healthcare segment, focused on diagnostic services and advanced imaging systems like solid-state gamma cameras, positions it within a market driven by ongoing demand for efficient and accurate medical diagnostics. Simultaneously, its construction segment, specializing in modular housing and engineered wood products, taps into the growing need for cost-effective and sustainable building solutions. Key value drivers include the potential for technological advancements in its imaging systems to capture market share and the increasing adoption of modular construction methods. However, the company's financial performance indicates significant challenges, with a reported market capitalization of $38.6M, a negative profit margin of -4.2%, and a negative Return on Equity (ROE) of -15.8%. These metrics highlight current unprofitability and a need for improved operational efficiency and revenue generation across its diverse business lines. The gross margin of 8.5% suggests limited profitability on sales before operating expenses. While the debt-to-equity ratio of 43.85 indicates moderate leverage, the company's small scale and current unprofitability introduce higher risk. Future growth catalysts would likely stem from successful market penetration of its advanced imaging technologies and capitalizing on the expansion of the modular construction market, provided it can achieve sustained profitability and scale its operations effectively.
Based on FMP financials and quantitative analysis
STRR Key Highlights
Market Capitalization: $38.6M, indicating a micro-cap company.
- Profit Margin: -4.2%, reflecting current unprofitability across its operations.
- Gross Margin: 8.5%, suggesting limited profitability on sales before operating expenses.
- Return on Equity (ROE): -15.8%, indicating negative returns on shareholder investments.
- Debt-to-Equity (D/E) Ratio: 43.85, showing a moderate level of financial leverage.
Who Are STRR's Competitors?
STRR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| IDXG Interpace Biosciences, Inc. | $6.51 | -6.73% | $36.1M | 519-signal |
| MDXH MDxHealth SA | $0.68 | -2.31% | $34.7M | — |
| QUCY QUCY | $1.39 | -0.01% | $31.6M | — |
| PRPO Precipio, Inc. | $26.91 | +5.12% | $48.0M | — |
| DRIO DarioHealth Corp. | $6.61 | -3.08% | $48.3M | 335-pillar |
| BIOQ Bioqual, Inc. | $33.00 | 0.00% | $29.5M | 389-signal |
| SERA Sera Prognostics, Inc. | $2.05 | +1.99% | $78.3M | — |
| BNGO Bionano Genomics, Inc. | $1.20 | +1.81% | $13.8M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are STRR's Key Strengths?
Diversified business model across healthcare diagnostics and construction materials, potentially mitigating sector-specific risks.
- Specialized technology in solid-state gamma cameras for advanced medical imaging.
- Established manufacturing and supply capabilities for modular housing and engineered wood products.
- Long operational history since 1985, indicating market experience.
What Are STRR's Weaknesses?
Consistent negative profit margin (-4.2%) and negative Return on Equity (-15.8%), indicating unprofitability.
- Small market capitalization ($38.6M), which can lead to higher stock price volatility and limited access to capital.
- Operational complexities and potential lack of synergies in managing two distinct and capital-intensive industries.
- Gross margin of 8.5% suggests limited profitability at the product level.
What Could Drive STRR Stock Higher?
STRR catalyst: Continued market penetration and adoption of the company's specialized solid-state gamma cameras in physician offices and hospitals, potentially driving increased sales and service contracts.
- Expansion of diagnostic imaging services into new geographic markets or through new partnership agreements, aiming to capture a larger share of the growing outpatient diagnostics sector.
- Potential for increased demand in the modular housing and engineered wood products segment, driven by governmental infrastructure spending initiatives or sustained housing market growth.
- Strategic optimization of the Investments segment, including potential real estate asset development or divestment, to generate additional capital or improve asset utilization.
What Are the Key Risks for STRR?
Financial-distress signal — its Altman Z-Score of -3.21 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-14.3%) — the business is not currently generating profit on shareholder capital.
- Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
- Sustained negative profit margin (-4.2%) and negative Return on Equity (-15.8%), indicating persistent unprofitability that could impact long-term financial viability and access to capital.
- Economic downturns or significant slowdowns in the construction sector could severely reduce demand for modular housing units and engineered wood products, impacting the company's revenue and profitability.
- Intense competitive pressures from larger, more established companies in both the medical diagnostics and construction materials industries, potentially limiting market share and pricing power.
- Adverse changes in healthcare regulations, reimbursement policies, or technological shifts could negatively affect the demand for diagnostic services and imaging systems.
- Volatility in raw material costs, particularly for wood products, which could erode gross margins in the construction segment if not effectively managed.
What Are the Growth Opportunities for STRR?
- Expansion of Diagnostic Services: Star Equity Holdings, Inc. has a significant opportunity to expand its diagnostic imaging services, particularly to cardiologists, internal medicine physicians, and family practice doctors. The market for outpatient diagnostic imaging continues to grow, driven by an aging population, increasing prevalence of chronic diseases, and a shift from inpatient to outpatient care settings. By expanding its geographic reach and potentially diversifying its service offerings within existing clinics or new partnerships, the company can capture a larger share of this essential healthcare service market. The demand for accessible and efficient diagnostic tools remains robust, providing a clear pathway for revenue growth in the medium to long term.
- Adoption of Solid-State Gamma Cameras: The company's development, sale, and maintenance of solid-state gamma cameras represent a key technological growth driver. Solid-state technology offers advantages over traditional systems, including improved image quality, faster acquisition times, and potentially lower operating costs. As healthcare providers seek more efficient and accurate diagnostic equipment, the adoption rate of such advanced systems is expected to increase. Star Equity Holdings, Inc. can capitalize on this trend by emphasizing the clinical benefits and operational efficiencies of its proprietary technology, targeting both physician offices and hospitals for upgrades or new installations over the next 3-5 years.
- Growth in Modular Construction: The modular housing and engineered wood products segment is poised for growth, driven by a global push for sustainable, efficient, and affordable construction methods. Addressing housing shortages and the need for rapid deployment of structures, modular construction offers reduced build times, minimized waste, and often higher quality control compared to traditional methods. Star Equity Holdings, Inc. can expand its market presence by increasing production capacity, developing new modular product lines, and forging partnerships with large-scale developers or government housing initiatives. This market is projected to see sustained growth over the next decade, presenting a substantial opportunity for the company's construction division.
- Strategic Investments and Asset Management: The Investments segment, which holds real estate assets and manages investments, offers a strategic avenue for growth and capital appreciation. By actively managing its real estate portfolio and making judicious investments, Star Equity Holdings, Inc. can generate additional revenue streams and enhance its overall asset base. This segment can also serve as a source of capital for reinvestment into its core healthcare and construction businesses, supporting organic growth or potential strategic acquisitions. Effective capital allocation and opportunistic real estate development or divestment could significantly contribute to the company's long-term financial health and shareholder value.
- International Market Penetration: While currently operating in the United States and internationally, there's an opportunity to deepen penetration in existing international markets or expand into new ones for both healthcare solutions and construction materials. Many developing and emerging economies have growing healthcare needs and significant demands for efficient, modern construction. By adapting its diagnostic services and imaging systems to local regulatory requirements and market preferences, and by exporting its modular housing and engineered wood products, Star Equity Holdings, Inc. can tap into larger global markets. This expansion could diversify revenue geographically and reduce reliance on any single national economy over the long term.
What Are STRR's Competitive Advantages?
- Specialized expertise and proprietary technology in nuclear cardiac and general purpose nuclear imaging systems, including solid-state gamma cameras.
- Diversified business model across distinct healthcare and construction sectors, potentially offering resilience against single-industry downturns.
- Established manufacturing capabilities and supply chain for modular housing and engineered wood products, supporting efficient production.
- Long-standing presence since 1985, indicating experience and established relationships in its operational markets.
What Does STRR Do?
Star Equity Holdings, Inc. (STRR), founded in 1985 and headquartered in Old Greenwich, Connecticut, has evolved into a diversified holding company with operations spanning both the healthcare and construction sectors. Originally known as Digirad Corporation, the company rebranded to Star Equity Holdings, Inc. in December 2020, reflecting its broader strategic focus. The company's business model is structured around four distinct segments: Diagnostic Services, Diagnostic Imaging, Construction, and Investments, enabling it to address diverse market needs in the United States and internationally. In its healthcare division, Star Equity Holdings, Inc. delivers essential diagnostic services primarily to cardiologists, internal medicine physicians, and family practice doctors, facilitating critical patient care. Complementing these services, the Diagnostic Imaging segment focuses on the development, sale, and maintenance of advanced imaging systems. This includes specialized nuclear cardiac and general purpose nuclear imaging systems, which are supplied to both physician offices and hospitals. A key technological offering in this segment is the company's solid-state gamma cameras, which it develops, sells, and supports through maintenance contract services, aiming to provide cutting-edge diagnostic tools to the medical community. Beyond healthcare, Star Equity Holdings, Inc. maintains a substantial presence in the construction industry. Through this segment, the company is involved in the manufacturing of modular housing units, structural wall panels, and permanent wood foundation systems. It also produces a range of other engineered wood products, catering to the growing demand for efficient and sustainable building solutions. Furthermore, the company acts as a supplier of various building materials to general contractors, supporting a wide array of construction projects. The fourth segment, Investments, encompasses the holding of real estate assets and the management of a diverse portfolio of investments, providing an additional layer of strategic asset management and potential capital appreciation for the company. This multi-faceted operational structure allows Star Equity Holdings, Inc. to pursue growth opportunities across different economic cycles and industry landscapes.
What Products and Services Does STRR Offer?
- Provide diagnostic imaging services, primarily to cardiologists, internal medicine physicians, and family practice doctors.
- Sell and maintain nuclear cardiac and general purpose nuclear imaging systems to physician offices and hospitals.
- Develop, sell, and service advanced solid-state gamma cameras for medical diagnostics.
- Manufacture modular housing units and structural wall panels for the construction industry.
- Produce permanent wood foundation systems and other engineered wood products.
- Supply various building materials to general contractors for diverse construction projects.
- Manage a portfolio of real estate assets and other strategic investments.
How Does STRR Make Money?
- Generates revenue from providing diagnostic imaging services under contractual agreements.
- Earns income through the direct sales of diagnostic imaging systems and solid-state gamma cameras.
- Secures recurring revenue from maintenance contracts for its installed base of imaging systems.
- Derives sales from the manufacturing and distribution of modular housing units and engineered wood products.
- Realizes returns and capital appreciation from its real estate holdings and managed investment portfolio.
What Industry Does STRR Operate In?
Star Equity Holdings, Inc. operates within a distinctive dual-industry framework, primarily spanning the Medical - Diagnostics & Research sector and the broader Construction materials market. In the healthcare domain, the company is positioned within a dynamic industry characterized by a continuous demand for advanced diagnostic tools and services. Market trends indicate a shift towards more efficient, non-invasive, and outpatient diagnostic solutions, particularly in cardiology and general internal medicine. The competitive landscape for diagnostic imaging systems is fragmented, with both large multinational corporations and specialized niche players vying for market share. Star Equity Holdings, Inc. differentiates itself with its specialized nuclear cardiac and general purpose nuclear imaging systems, including proprietary solid-state gamma cameras, aiming for precision and technological advantage. Concurrently, the company's Construction segment operates in a market driven by factors such as housing demand, infrastructure development, and the increasing adoption of prefabrication and modular construction techniques. This segment addresses the need for efficient, sustainable, and often more affordable building solutions, including modular housing units and engineered wood products. The construction materials market is highly competitive and sensitive to economic cycles, raw material costs, and labor availability. Star Equity Holdings, Inc. leverages its manufacturing capabilities to supply general contractors, positioning itself as a provider of specialized building components. The company's unique diversification across these two distinct sectors presents both opportunities for cross-cyclical stability and challenges in managing disparate operational complexities and market dynamics.
Who Are STRR's Key Customers?
- Cardiologists, internal medicine physicians, and family practice doctors utilizing diagnostic services.
- Physician offices, clinics, and hospitals purchasing imaging systems and maintenance contracts.
- General contractors and construction companies acquiring modular units and building materials.
- Real estate developers and property owners involved in various construction projects.
- The company's own investment segment, which manages its capital and real estate assets.
Research confidence
Broad, current evidence sits behind this analysis.
- ● Scored on 91% of our measures
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
Why 24?
Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.
What is helping
- +0.78 Gross profit per dollar of assets (Business Quality)
- +0.54 Enterprise value vs sales (Valuation)
- +0.48 Revenue growth (Growth)
What is holding it back
- -0.78 Free cash flow yield (Business Quality)
- -0.54 Earnings yield (Valuation)
- -0.54 Free cash flow yield (Valuation)
Risk penalties applied
- -1.89 Bankruptcy-risk score in the distress zone
- -1.23 Loss-making with negative retained earnings
Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 22 |
| 2026-08-26 | 22 |
| 2026-08-29 | 22 |
| 2026-09-01 | 24 |
| 2026-09-04 | 24 |
| 2026-09-07 | 24 |
| 2026-09-10 | 24 |
What changed?
The grade moved from 22 to 24 (+2).
What moved it up or down:
- +27 Valuation
- +11 Momentum
- +4 Business Quality
Held back by:
- -18 Financial Strength
- -4 Growth
Over the same 18 days the stock moved +4.1%.
Star Equity Holdings, Inc. (STRR) Valuation Context
Valued at $38.6M, STRR is classified as a micro-cap stock. Relative to its peer group, STRR's quantitative score of 24/100 is below the peer average of 41/100.
STRR Revenue & Earnings Trend
In Q2 FY2026, STRR generated $54.9M in top-line revenue, marking a sequential increase of 9.7%. The company recorded a net loss of $1.8M, with diluted EPS of $-0.50. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, STRR averaged $-0.63 in diluted EPS.
Company Profile
Star Equity Holdings, Inc. operates in the Conglomerates industry within the Industrials sector. It is headquartered in Old Greenwich, US. The company is led by CEO Jeffrey E. Eberwein. STRR has traded publicly since 2004.
Key Financial Metrics
Return on equity for Star Equity Holdings, Inc. stands at -14.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -8.4%, showing how much profit it generates from its asset base. Its free cash flow yield is -36.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.96 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -23.5%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Star Equity Holdings, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -3.21 places it in the distress zone, a signal of elevated financial risk.
Earnings Track Record
Star Equity Holdings, Inc. has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 413.2% below estimates on average.
Insider Activity
Over the past six months, Star Equity Holdings, Inc. insiders filed 30 SEC Form 4 transactions — 8 sales and 22 purchases. On net that is roughly 47K shares acquired (about $464K) — insiders putting money in tends to read as conviction.
STRR Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Diversified business model across healthcare diagnostics and construction materials, potentially mitigating sector-specific risks.
- Specialized technology in solid-state gamma cameras for advanced medical imaging.
- Established manufacturing and supply capabilities for modular housing and engineered wood products.
- Long operational history since 1985, indicating market experience.
Bear Case
- Consistent negative profit margin (-4.2%) and negative Return on Equity (-15.8%), indicating unprofitability.
- Small market capitalization ($38.6M), which can lead to higher stock price volatility and limited access to capital.
- Operational complexities and potential lack of synergies in managing two distinct and capital-intensive industries.
- Gross margin of 8.5% suggests limited profitability at the product level.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $55M | -$2M | -$0.50 |
| Q1 FY2026 | $50M | -$4M | -$1.01 |
| Q4 FY2025 | $57M | -$2M | -$0.48 |
| Q3 FY2025 | $48M | -$2M | -$0.54 |
Q2 FY2026 · filed 30 Jun 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
STRR Latest News
-
Star Equity (STRR) Q2 2026 Earnings Call Transcript
Yahoo! Finance: STRR News · Aug 21, 2026
-
Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock
globenewswire.com · Aug 21, 2026
-
Star Equity Holdings, Inc. Q2 2026 Earnings Call Summary
Yahoo! Finance: STRR News · Aug 15, 2026
-
Star Equity Holdings Inc (STRR) (Q2 2026) Earnings Call Highlights: Merger Synergies and ...
Yahoo! Finance: STRR News · Aug 14, 2026
STRR Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for STRR.
Price Targets
Wall Street price target analysis for STRR.
STRR MoonshotScore
What does this score mean?
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. STRR scores 24/100 (Grade F): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Latest News
Star Equity (STRR) Q2 2026 Earnings Call Transcript
Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock
Star Equity Holdings, Inc. Q2 2026 Earnings Call Summary
Star Equity Holdings Inc (STRR) (Q2 2026) Earnings Call Highlights: Merger Synergies and ...
What Investors Ask About Star Equity Holdings, Inc. (STRR) — Healthcare
What does the AI Score mean for STRR?
STRR holds an AI Score of 24/100 (Grade: F). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Is STRR a good stock?
Stock Expert AI does not rate STRR buy, sell or hold. Star Equity Holdings, Inc. carries a MoonshotScore of 24/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the primary growth drivers for Star Equity Holdings, Inc. in the healthcare sector?
In the healthcare sector, Star Equity Holdings, Inc. has several key growth drivers. One significant driver is the expanding demand for outpatient diagnostic imaging services, particularly among cardiologists and internal medicine physicians, driven by an aging population and increasing chronic disease prevalence. The company's ability to expand its service footprint and client base will be crucial.
What are the key factors to evaluate for STRR?
Star Equity Holdings, Inc. (STRR) holds an AI score of 24/100 (low). The demand for accessible and efficient diagnostic tools remains robust, providing a clear pathway for revenue growth in the medium to long term. Not financial advice.
How frequently does STRR data refresh on this page?
STRR's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven STRR's recent stock price performance?
Star Equity Holdings, Inc. (STRR) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business model across healthcare diagnostics and construction materials, potentially mitigating sector-specific risks. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider STRR overvalued or undervalued right now?
Star Equity Holdings, Inc. (STRR) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of STRR?
Yes, most major brokerages offer fractional shares of Star Equity Holdings, Inc. (STRR) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track STRR's earnings and financial reports?
Star Equity Holdings, Inc. (STRR) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for STRR earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial details provided beyond key metrics.
- Specific market sizes and timelines for growth opportunities are inferred due to lack of explicit data.